ArticleThe Journal of clinical investigation2011

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.

Christian Besler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.